<div><div class="gmail_quote"><div><br></div><br><br>
<div lang="EN-US" link="#0563C1" vlink="#954F72">
<div class="m_6213747446013872426WordSection1">
<p class="MsoNormal">All,<u></u><u></u></p>
<p class="MsoNormal"><u></u> <u></u></p>
<p class="MsoNormal">Attached in Word and PDF is the almost final Draft Report, based on today’s call. This is also available in Google Docs at
<a href="https://docs.google.com/document/d/1rdMJyvZdyN9TApT6gx_3NwpdvIL7YKHEUD7tNfLf6hU/edit?usp=sharing" target="_blank">
https://docs.google.com/document/d/1rdMJyvZdyN9TApT6gx_3NwpdvIL7YKHEUD7tNfLf6hU/edit?usp=sharing</a>.
<u></u><u></u></p>
<p class="MsoNormal"><u></u> <u></u></p>
<p class="MsoNormal">Please review and comment. I have marked in the margin the sections corresponding to the “Notes” in the chart distributed before today’s call.<u></u><u></u></p>
<p class="MsoNormal"><u></u> <u></u></p>
<p class="MsoNormal">In particular please review and respond to the suggested text on page 12 at the end of the “Overview of the Work of the Subgroup.” There are two proposed additions that grew out of Note 4.1. The first received broad support on the call
without noted objections.<u></u><u></u></p>
<p class="MsoNormal"><u></u> <u></u></p>
<p class="MsoNormal">The second received both support and objections on the call. Since there was no clear path forward from the call, it is important that as many participants as possible give this careful consideration and provide their views on this second
proposed addition. This text reads as follows:<u></u><u></u></p>
<p class="MsoNormal"><u></u> <u></u></p>
<p class="MsoNormal" style="margin-left:.5in">The late suggestion added to the report that “Further Discussions of Jurisdiction-Related Concerns” are needed, in particular on jurisdictional immunities, found echo in several comments subsequently received, but
these comments did not bring any changes to the report, nor could they be considered in detail, on the understanding that the existing support for “further discussions” to address unresolved concerns, including in other fora, had already been acknowledged.<u></u><u></u></p>
<p class="MsoNormal"><u></u> <u></u></p>
<p class="MsoNormal">I look forward to hearing from you all, with regard to the report as a whole and any specific aspects, in particular the proposed text above.<u></u><u></u></p>
<p class="MsoNormal"><u></u> <u></u></p>
<p class="MsoNormal">Since the final draft must be submitted no later than 23:59 UTC on 2 March, I am setting
<b>a deadline of 18:00 UTC on 2 March</b> for all responses.<u></u><u></u></p>
<p class="MsoNormal"><u></u> <u></u></p>
<p class="MsoNormal">Thank you!<u></u><u></u></p>
<p class="MsoNormal"><u></u> <u></u></p>
<p class="MsoNormal">Greg<u></u><u></u></p>
<p class="MsoNormal"><u></u> <u></u></p>
</div>
<br>
<font color="#999999">_________________________________________________________________</font>
<br>
<font size="-1" color="#999999">This message is being sent from a Law Firm and may contain CONFIDENTIAL or PRIVILEGED information. If you are not the intended recipient, do not print, copy or distribute this message or any attachments. Advise the sender immediately
by reply e-mail, and delete this message and attachments without retaining a copy.
</font><br>
<br><br><p style="font-family:Verdana;font-size:10pt;color:#666666"><b>Disclaimer</b></p><p style="font-family:Verdana;font-size:8pt;color:#666666">The information contained in this communication from the sender is confidential. It is intended solely for use by the recipient and others authorized to receive it. If you are not the recipient, you are hereby notified that any disclosure, copying, distribution or taking action in relation of the contents of this information is strictly prohibited and may be unlawful.<br><br>This email has been scanned for viruses and malware, and may have been automatically archived by <b>Mimecast Ltd</b>, an innovator in Software as a Service (SaaS) for business. Providing a <b>safer</b> and <b>more useful</b> place for your human generated data. Specializing in; Security, archiving and compliance. To find out more <a href="http://www.mimecast.com/products/" target="_blank">Click Here</a>.</p></div>
</div></div>